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Detection of postural sway abnormalities
by wireless inertial sensors in minimally
disabled patients with multiple sclerosis: a
case–control study
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Abstract
Background: Common clinical neurological exams can be insensitive to balance and mobility impairment at the
early stages of multiple sclerosis (MS) and may not correspond with patient reports. Instrumented measurement of
standing postural sway with inertial motion sensors may provide sensitive measures of balance impairment and
better correspond with patient reports.
Methods: While wearing wireless inertial sensors, 20 subjects with MS – Expanded Disability Status Scale of less
than 3.0 and a Timed 25 Foot Walk of 5 sec or less – and 20 age- and sex-matched control subjects stood with
eyes open and eyes closed on a foam surface. Forty-six outcome measures of postural sway were derived. A
stepwise logistic regression model determined which measures of instrumented sway provide independent
predictors of group status. Subjects with MS also completed the Activities-Specific Balance Confidence (ABC) scale
and the 12-Item MS Walking Scale (MSWS-12) as measures of subject-reported balance and mobility impairment.
Results: The regression model identified medio-lateral sway path length and medio-lateral range of sway
acceleration amplitude, each in the eyes-open condition, as the only two significant independent predictors to
differentiate subjects with MS from those without MS (model chi-squared = 34.55, p < 0.0001): accuracy = 87.5 %,
positive likelihood ratio = 6 (2.09–17.21), negative likelihood ratio = 0.12 (0.03–0.44). Range of sway acceleration
amplitude significantly correlated with both ABC (Spearman’s r = −0.567, p = 0.009) and MSWS-12 scores
(Spearman’s r = −0.590, p = 0.006).
Conclusions: Postural sway abnormalities in subjects with MS who are minimally disabled were detected using
wireless inertial sensors and may signify a superior sensitivity to identify balance impairment prior to developing
clinically evident disability or impaired gait speed. Further study is needed to confirm the clinical significance and
predictive value of these objectively identified balance impairments.
Background
Balance impairment is common in people with multiple
sclerosis (MS) and frequently impacts quality of life by
decreasing mobility and increasing the risk for falls
[1, 2]. The causes of balance dysfunction in MS are
not well understood. More sensitive measures of
balance impairment are needed to better understand
mechanisms of postural control affected by MS.
A number of clinical and self-reported measures have
been utilized to evaluate balance impairment in patients
with MS. Current clinical measures of walking and bal-
ance in MS frequently used for clinical trials and clinical
decision-making include the Expanded Disability Status
Scale (EDSS) and Timed 25-Foot Walk (T25FW) Test.
The EDSS, however, is heavily weighted toward ambula-
tory disability and is less sensitive to other dimensions
of disability, may not perform well in patients with
milder disability, and has been critiqued for insensitivity
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to detect changes in level of disability [3–5]. A worsen-
ing of 20 % or more on the T25FW appears to reliably
indicate progression of disability, however patients min-
imally affected by MS frequently walk 25 feet between 3
and 5 sec, [6, 7] which is below the 6-second threshold
associated with accrual of significant disability [8]. Thus,
a 20 % change in walk time may be relatively insensitive
to disability progression during the early stages of MS.
The Brief-BESTest [9] is an 8-item clinical assessment of
balance impairment that was specifically designed to
evaluate multiple contexts of balance and gait impair-
ment. The Brief-BESTest has shown promise to identify
fall risk in people with MS and is sensitive to change fol-
lowing a balance exercise intervention for people with
MS [9, 10]. The Brief-BESTest, therefore, may offer a
more comprehensive clinical evaluation of balance im-
pairment [11] than the EDSS or T25FW, but it remains
unclear if this clinical tool better differentiates people at
early stages of MS from people without MS, or if instru-
mented measures of balance impairment might be
necessary.
In addition to clinical assessments often being insensi-
tive to differences between people with early-stage MS
and people without MS, patients with MS sometimes
report difficulties with mobility or balance despite
normal clinical tests [12]. The MS Walking Scale-12
(MSWS-12) [13, 14] is a widely used self-reported rating
scale used to assess the impact of MS on walking ability
that includes questions concerning walking and balance
impairment. The Activities-Specific Balance Confidence
(ABC) Scale is a 16-item self-report measure in which
patients rate their balance confidence for performing ac-
tivities [15] and has demonstrated validity for patients
with MS, [16] as well as associations with objective, in-
strumented measures of balance [1]. An effective balance
assessment, therefore, should not only be sensitive to
early changes in balance and mobility due to MS, but it
should also better reflect patient reports of balance and
mobility impairment as identified by measures such as
the ABC scale and MSWS-12.
There remains a significant need for an objective,
practical, sensitive and predictive clinical measure of bal-
ance impairment in MS that shows a strong association
with patient-reported symptoms. Use of body-worn
wireless inertial sensors may provide more sensitive
measures of balance impairment than current clinical
measures while also enabling ease of clinical implemen-
tation compared to traditional kinematic methodology
[17]. Measurements using inertial sensors have demon-
strated in patients with other neurological disease, such
as Parkinson’s disease, an ability to discriminate subjects
with early disease compared to controls, correlation with
disease severity, and sensitivity to early progression of
postural sway abnormalities [18–21]. In a study by Spain
and colleagues, such sensors have demonstrated abnor-
mal standing postural sway in subjects with MS who
present with normal walking times when compared to
subjects without MS [22]. The predictive capacity of
these measures to differentiate groups with and without
MS, however, was of only moderate strength (areas
under the receiver operating characteristic curves ranged
from 0.39 to 0.72) [22]. In that study by Spain and col-
leagues, though, subjects were only tested for standing
postural sway on a firm surface; other studies have sug-
gested that postural sway is most impacted by MS when
modifying sensory input, such as when standing on a
compliant surface [23]. Thus, it remains necessary to
(1) maximize the potential sensitivity of body-worn
sensors to differentiate subjects with and without MS
by testing conditions known to do so, and (2) examine
the predictive capacity of instrumented standing sway
measures to differentiate subjects without MS from
subjects selected specifically to have early-stage MS.
The purpose of this study is to determine if instru-
mented measures of standing postural sway (using body-
worn inertial motion sensors) can differentiate people
with MS chosen for minimal impairment and clinically
normal gait times from people without MS while also
corresponding with subject-reported balance and gait
difficulty. In spite of clinical tests suggesting minimal
disability, such patients may identify problems with bal-
ance and mobility and, therefore, we included subject-
reported measures to determine in this cohort with
minimal impairments if instrumented measures corres-
pond to subject perception of balance (ABC) and gait
(MSWS-12). Prior studies have supported that a variety
of instrumented measures can correspond to subject-
reported measures of balance impairment in subjects
with MS [1, 24, 25]. We thus hypothesized that instru-
mented measures of standing postural sway would
differentiate subjects with and without MS, despite clin-
ically normal gait speed and minimal clinically defined
disability, and associate with self-reported measures of
balance impairment. Unlike prior studies that have uti-
lized body-worn inertial sensors [22, 26], this study eval-
uated stance on a compliant foam surface in order to
determine if instrumented measures of sway in this
more challenging condition can provide discriminative
validity to identify people with minimally impaired MS
from control subjects without MS.
An improved understanding of balance impairment in
people with minimally disabling MS through more sensi-
tive measures, such as those derived from body-worn in-
ertial sensors, may allow the identification of biomarkers
to guide early therapeutic interventions. Therapeutic de-
cisions made before the onset of significant disability
may play an important role in modifying disease trajec-
tory and preserving mobility as well as quality of life.
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Methods
Subjects
After written informed consent, 20 people with MS and
20 without MS completed the protocol, which was ap-
proved by the local Institutional Review Board. Inclusion
criteria for the subjects with MS included: (1) diagnosis
of MS with an EDSS of less than 3.0, (2) T25FW of 5 sec
or less, (3) age 18–70, (4) ability to stand unassisted, and
(5) an ability to walk without an assistive device, includ-
ing a cane or walker. Exclusion criteria for the subjects
with MS included: (1) current use of Dalfampridine
medication, (2) use of an ankle-foot orthotic, (3) MS re-
lapse in the last 3 months, (4) previous foot, knee, or hip
surgery, (5) severe pain that limited mobility, (6) signifi-
cant vision impairment limiting mobility or balance, and
(7) any additional neurological or medical conditions
that may impair walking or balance, including but not
limited to stroke, neuropathy, low back pain, depression,
or arthritis.
The control group of subjects without MS included
subjects aged 18–70, and exclusion criteria included any
known medical diagnoses or current medication that
might impair or influence balance. These included, but
were not limited to: (1) any diagnosed neurological
disorder or neurological symptoms other than episodic
migraine, (2) any diagnosed inner ear or vestibular dis-
order, (3) persistent musculoskeletal pain, (4) a history
of orthopedic surgery that might impair balance, includ-
ing foot, ankle, leg, knee, hip, or spine surgery, (5) a
current diagnosed psychiatric disorder such as depres-
sion or anxiety, or (6) use of medications that may
affect the central nervous system, including opioids and
benzodiazepines.
Protocol
Prior to instrumented measurement of balance, only
the subjects with MS completed the 12-Item MS
Walking Scale (MSWS-12) and Activities-Specific
Balance Confidence Scale (ABC).
Subjects with MS and control subjects without MS
participated in the instrumented measurement of postural
sway. The instrumented task was to stand on a foam sur-
face with either eyes open or eyes closed. Body-worn sen-
sors using the Opal system (©APDM, www.apdm.com)
were utilized for the study. The Opal system consists
of small, lightweight, body-worn sensors that contain
3-dimensional gyroscopes, accelerometers, and mag-
netometers. Six sensors were strapped to the subjects’
bodies at the sternum, lumbar area, wrists and ankles.
The sensors wirelessly transmit their raw data at 120 Hz
to a laptop data collection system.
Instrumented postural sway (iSWAY) was performed
while subjects were standing on 10.16 cm of medium-
density foam with their feet in a standardized position
using a footplate. The footplate was 15.24 cm wide be-
tween the top of the feet and 10.48 cm between the
heels, creating an angle of 17.3° between feet. The sub-
jects were instructed to stand as still as possible for
30 sec with their arms crossed and hands on their shoul-
ders. Three trials each were performed in an eyes-open
(EO) and eyes-closed (EC) condition for a total of six tri-
als. The subjects stepped off the foam between each trial
for approximately 1 min to rest. The total time required
to complete iSWAY for each individual was approxi-
mately 10 to 15 min, which included instructions for the
task as well as placement and removal of sensors and
software validation of each trial.
Following the instrumented measures, only the sub-
jects with MS completed the T25FW, Brief-BESTest, [9]
and an EDSS exam performed by a neurologist with
post-doctoral subspecialty training in MS and certifica-
tion to perform EDSS exams for clinical trials. Subjects
with MS were offered time to rest as needed between
each measure, no subject complained of fatigue after
completion of the protocol.
Data processing & analysis
Forty-six outcome measures were automatically derived
and exported using the Mobility Lab software algorithms
(©APDM) [17, 27]. These include multiple measures
representing amount, velocity, acceleration, jerk, and
spectral power of sway in the anterior-posterior and
medial-lateral directions as well as in the combined hori-
zontal plane. Since all 46 measures are readily available
to a clinician or researcher, each was considered in the
analysis following correction for multiple comparisons.
Each subject’s measures were averaged by trial and visual
condition for analysis. Clinical balance and gait impair-
ments were tested by the Brief-BESTest [9] and T25FW
test [8]. Sum Brief-BESTest scores and 25-foot walk
times were derived for analysis. Subject-reported mea-
sures of balance and gait difficulty were derived from
the average score of the ABC scale [15] and the percent-
age score of the MSWS-12 [13].
Because Shapiro-Wilks tests of normality often deter-
mined that the data did not meet requirements for nor-
mality, differences in each measure of instrumented
sway between the groups with and without MS were de-
termined using Mann–Whitney U tests. Because 46
measures of sway were determined and assessed twice
(once for each visual condition; total = 92 comparisons),
significance was set to a Bonferroni-corrected value of
0.00054. A forward, likelihood-ratio, stepwise logistic re-
gression model was used to determine which measures
of instrumented sway provide independent predictors of
group status (i.e., subjects with early-stage MS versus
subjects without MS). Variables entered into the model
included only the measures that were significantly
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different between groups based on the Mann–Whitney
U tests.
Spearman’s rho correlation coefficients were used to
evaluate associations between the instrumented sway
measures identified as significant independent predictors
of group status and the subject-reported measures of
balance and gait difficulty (the ABC scale and MSWS-12).
Likewise, Spearman’s coefficients were used to evaluate as-
sociations between clinical exam scores (Brief-BESTest,
T25FW, and EDSS) and the subject-reported measures of
balance and gait difficulty. The Mann–Whitney U tests
and regression analysis, thus, serve to test the hypothesis
that instrumented measures of standing postural sway can
differentiate subjects with early-stage MS from subjects
without MS; the correlation analysis determined whether
the instrumented measures of postural sway that differenti-
ate subjects based on group status or the clinical-exam




Both groups with and without MS were comprised of
four males and 16 females with mean (95 % CI) ages of
40 (35–45) years. Demographic and clinical characteris-
tics of the group with MS are displayed in Table 1.
Group differences in instrumented sway variables
In the eyes-open condition, following Bonferroni correc-
tion, 15 of the 46 instrumented measures of sway were
significantly different between the groups with and with-
out MS (Table 2); in the eyes-closed condition, 22 of the
46 measures were significantly different between groups
(Table 3).
The stepwise logistic regression model identified sway
path length and the range of sway acceleration ampli-
tude in the medial-lateral direction and eyes-open condi-
tion as the only two significant independent predictors
to differentiate subjects with MS from those without MS
(model chi-squared = 34.55, p < 0.0001): specificity = 85 %,
sensitivity = 90 %, accuracy = 87.5 %, area under receiver
operating characteristics curve = 0.957 (0.90–1.0), positive
likelihood ratio = 6 (2.09–17.21), negative likelihood
ratio = 0.12 (0.03–0.44). Individually, the area under
the curve for the range of acceleration amplitude alone
was 0.908 (0.81–1.0), and that for sway path length alone
was 0.905 (0.82–1.0). A cutoff value of 0.216 m/s2 for the
range of acceleration amplitude provided 80 % sensitivity
and 95 % specificity. A cutoff value of 4.0 m/s2 for the sway
path length provided 85 % sensitivity and 80 % specificity.
Correlating subject-reported measures with instrumented
sway measures or clinical-exam measures
All correlation analyses with the subject-reported mea-
sures of balance and gait difficulty (ABC scale and
MSWS-12) are illustrated in Fig. 1. As the significant in-
dependent predictors of group status, medial-lateral
sway path length and range of sway acceleration ampli-
tude were selected in the correlation analysis with
subject-reported measures of balance and gait difficulty.
The range of sway acceleration amplitude, but not sway
path length, significantly correlated with ABC-scale and
MSWS-12 scores. Although the T25FW did not generate
significant correlations with ABC-scale or MSWS-12
scores, the Brief-BESTest significantly correlated with
both self-report measures and the EDSS significantly
correlated with ABC-scale scores but not MSWS-12
scores.
Discussion
Our results demonstrate that instrumented measures of
standing sway were able to differentiate subjects without
MS from those with minimally disabling MS and clinic-
ally normal gait speed. Medial-lateral sway path length
and range of sway acceleration in the eyes-open condi-
tion provided the strongest independent predictors of
group status. The range of sway acceleration amplitude
in the medial-lateral direction and eyes-open condition
also significantly correlated with subject-reported mea-
sures of balance and gait difficulty. These subjects re-
ported high levels of balance confidence and low impact
of MS on mobility using these measures. These observa-
tions could reflect ceiling and floor effects of the ABC
and MSWS-12, suggesting that these test instruments
are not sensitive enough to detect initial changes in the
quiet sway of a minimally impaired cohort. In contrast,
gait speed (as measured by T25FW) was not associated
with subject perceptions of balance and gait impairment;
EDSS scores exhibited a weaker correlation with balance
confidence and no significant association with self-
reported gait impairment. The Brief-BESTest exhibited
the strongest correlations to both the ABC-scale and
MSWS-12 scores. Thus, the instrumented measure of
range of sway acceleration amplitude in the medial-
lateral direction appears capable of identifying balance
Table 1 MS cohort demographic and clinical characteristics
aGender Four male 16 female
aAge (95 % CI) 40 (35–45)
Years since diagnosis (95 % CI) 4 (1–7)
EDSS median (range) 2.0 (1.0–2.5)
T25FW (95 % CI) 3.9 (3.6–4.1)
Brief-BESTest (95 % CI) 22 (21–23)
ABC (95 % CI) 96 (93–99)
MSWS-12 (95 % CI) 14 (5–22)%
aControl subjects without MS were age and gender matched to subjects
with MS
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Table 2 Mean (95 % CI) measures of sway with significant group differences: eyes open
*Instrumented measure of sway Group with MS Control group Mann–Whitney U
(p-value)
ML jerk (m2/s5) 0.0092 (0.0064–0.0120) 0.0030 (0.0023–0.0037) 25 (p < 0.0001)
Horizontal sway area (m2/s4) 0.0086 (0.0064–0.0108) 0.0038 (0.0032–0.0045) 37 (p < 0.0001)
95 % confidence circle area (m2/s4) 0.099 (0.076–0.121) 0.049 (0.037–0.061) 63 (p = 0.0001)
95 % confidence ellipse area (m2/s4) 0.083 (0.060–0.105) 0.034 (0.028–0.041) 49 (p < 0.0001)
AP root mean square (m/s2) 0.084 (0.075–0.093) 0.062 (0.054–0.070) 73 (p = 0.00036)
Horizontal root mean square (m/s2) 0.101 (0.089–0.113) 0.071 (0.063–0.078) 62 (p < 0.0001)
ML root mean square (m/s2) 0.052 (0.042–0.062) 0.031 (0.027–0.036) 70 (p = 0.00026)
AP mean sway velocity (m/s) 0.221 (0.189–0.254) 0.149 (0.116–0.183) 72 (p = 0.00032)
Horizontal mean sway velocity (m/s) 0.278 (0.233–0.324) 0.187 (0.157–0.216) 69 (p = 0.00022)
AP sway radius (m/s2) 0.068 (0.061–0.075) 0.050 (0.043–0.057) 74 (p = 0.00042)
Horizontal sway radius (m/s2) 0.088 (0.077–0.098) 0.061 (0.055–0.067) 62 (p < 0.0001)
ML sway path length (m/s2) 5.23 (4.54–5.93) 3.22 (2.82–3.61) 38 (p < 0.0001)
Horizontal range of acceleration (m/s2) 0.541 (0.478–0.604) 0.382 (0.340–0.423) 63 (p = 0.0001)
ML range of acceleration (m/s2) 0.293 (0.247–0.340) 0.164 (0.147–0.182) 37 (p < 0.0001)
ML total spectral power (m2/s4) 0.812 (0.561–1.063) 0.230 (0.199–0.262) 27 (p < 0.0001)
*ML medial-lateral; AP anterior-posterior; units reflect measures are derived from an acceleration signal; significance defined as p< 0.00054 after Bonferroni correction
Table 3 Mean (95 % CI) measures of sway with significant group differences: eyes closed
*Instrumented measure of sway Group with MS Control group Mann–Whitney U
(p-value)
AP jerk (m2/s5) 0.274 (0.000–0.609) 0.027 (0.020–0.033) 60 (p < 0.0001)
Horizontal jerk (m2/s5) 5.72 (0.000–12.19) 0.521 (0.413–0.629) 57 (p < 0.0001)
ML jerk (m2/s5) 0.151 (0.000–0.335) 0.0066 (0.0051–0.0082) 33 (p < 0.0001)
Horizontal sway area (m2/s4) 0.146 (0.000–0.317) 0.012 (0.010–0.015) 47 (p < 0.0001)
95 % confidence circle area (m2/s4) 1.533 (0.317–2.749) 0.207 (0.167–0.247) 62 (p < 0.0001)
95 % confidence ellipse area (m2/s4) 1.043 (0.081–2.005) 0.128 (0.101–0.154) 43 (p < 0.0001)
AP root mean square (m/s2) 0.249 (0.175–0.323) 0.129 (0.118–0.140) 68 (p = 0.0002)
Horizontal root mean square (m/s2) 0.291 (0.195–0.388) 0.144 (0.131–0.156) 59 (p < 0.0001)
ML root mean square (m/s2) 0.140 (0.075–0.204) 0.057 (0.047–0.068) 58 (p < 0.0001)
Horizontal mean sway velocity (m/s) 0.689 (0.536–0.841) 0.403 (0.346–0.459) 76 (p = 0.00053)
AP sway radius (m/s2) 0.191 (0.139–0.242) 0.103 (0.094–0.113) 71 (p = 0.00028)
Horizontal sway radius (m/s2) 0.236 (0.166–0.307) 0.122 (0.111–0.133) 56 (p < 0.0001)
ML sway radius (m/s2) 0.101 (0.062–0.140) 0.046 (0.037–0.055) 57 (p < 0.0001)
AP sway path length (m/s2) 16.08 (11.68–20.48) 8.76 (7.82–9.69) 67 (p = 0.00018)
Horizontal sway path length (m/s2) 21.78 (15.52–28.04) 10.74 (9.68–11.81) 51 (p < 0.0001)
ML sway path length (m/s2) 11.28 (7.89–14.67) 4.54 (4.01–5.08) 30 (p < 0.0001)
AP range of acceleration (m/s2) 1.469 (0.928–2.011) 0.693 (0.636–0.751) 66 (p = 0.00016)
Horizontal range of acceleration (m/s2) 1.768 (1.020–2.516) 0.769 (0.705–0.834) 51 (p < 0.0001)
ML range of acceleration (m/s2) 0.928 (0.405–1.452) 0.307 (0.258–0.356) 48 (p < 0.0001)
AP total spectral power (m2/s4) 31.63 (7.17–56.10) 4.14 (3.42–4.85) 69 (p = 0.00023)
Horizontal total spectral power (m2/s4) 17.46 (4.57–30.34) 2.40 (2.02–2.78) 48 (p < 0.0001)
ML total spectral power (m2/s4) 12.92 (0.00–28.81) 0.641 (0.504–0.778) 31 (p < 0.0001)
*ML medial-lateral; AP anterior-posterior; units reflect measures are derived from an acceleration signal; significance defined as p< 0.00054 after Bonferroni correction
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Fig. 1 Scatter plots demonstrating the strength of Spearman’s correlations of subject-reported measures (ABC scale and MSWS-12) versus instrumented
sway measures found to differentiate between people with and without MS (medial-lateral (ML) range of acceleration amplitude and sway path length
in the eyes-open (EO) condition) as well as clinical measures of impairment and disability (Brief-BESTest, EDSS, and T25FW)
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impairment in minimally disabled patients with MS and
with stronger associations with subject-reported experi-
ences than those provided by the T25FW or EDSS
exams.
Numerous studies have found balance impairment in
individuals with MS at varying levels of disability [2].
Our MS cohort included individuals who were “minimally
disabled” or “early-stage” as determined by EDSS scores
and T25FW times that specify clinically meaningful bench-
marks for disease progression and disability [8, 28, 29]. Al-
though the definitions of “minimally” or “mildly” disabled
have varied with methodology, our data also supports the
identification of abnormalities of postural sway in people
with MS at a similar level of disability in a number of
instrumented studies [12, 22, 24, 25, 30–36].
Our results compliment past studies on postural sway
in people with MS. In subjects minimally disabled with
MS, past studies of posturography have identified higher
sway velocities [25] and differences in the range of trunk
roll [12] compared to control subjects without MS. In
addition, center-of-pressure measurements in previous
studies have demonstrated greater root-mean-square
velocity [34] and altered medial-lateral and anterior-
posterior sway variability with the removal of vision [30].
In our study, numerous measures in both the medial-
lateral and anterior-posterior directions were also signifi-
cant, and differences between subjects with and without
MS were also evident in both the EO and EC conditions.
Although many measures were identified as different be-
tween groups with the eyes closed, the stepwise regres-
sion analysis only included two measures derived from
the EO condition. Some specificity may be lost for differen-
tiating individuals with and without mild MS in the EC
condition because the task is also challenging for healthy
adults in the EC condition. As such, despite many impair-
ments being evident with the eyes closed, the best predic-
tors of early-stage MS were evident with the eyes open.
Sway velocity has also been reported to associate with
clinical exams and self-report of balance impairment
such as the Berg Balance Scale, ABC scale, and EDSS
[1]. In contrast, some studies have demonstrated balance
disorders undetectable by more widely used scales in
people with MS [32, 33]. This study found that instru-
mented sway measures provided both the capacity to
differentiate people with early-stage MS from people
without MS and the capacity to correspond with
subject-reported balance and gait difficulty, whereas the
EDSS and T25FW either did not correlate as strongly
with self-report measures or (by nature of our subject
sample criteria) exhibited values that would not likely
identify balance and mobility impairment in subjects
with versus without early-stage MS.
This study’s objective was focused on the discrimina-
tive validity of instrumented sway measures. Thus, our
control subjects without MS did not complete the clin-
ical exam items. Unfortunately, we are therefore unable
to compare the Brief-BESTest’s discriminative validity in
this cohort of clinically minimal disability and normal
gait speed. The mean and 95 % confidence interval of
this study’s cohort with MS were relatively high, suggest-
ing the Brief-BESTest would not be as powerful as the
instrumented sway measures to discriminate people with
versus without early-stage MS. Although speculative, if
we examine each individual’s score compared to the
95 % confidence intervals of age-normative values pre-
sented in other studies, [9, 37] we identified nine of our
20 subjects with MS as having scores below these confi-
dence intervals. Therefore, in combination with the
correlation analysis that demonstrated significant corre-
lations between Brief-BESTest scores and subject-
reported balance and mobility difficulty, our results sug-
gest at least a moderate discriminative validity for the
Brief-BESTest. Compared to the sensitivity and specifi-
city provided by the instrumented sway measures,
though, we speculate that the Brief-BESTest’s accuracy
would not likely reach similar levels. These combined re-
sults of the EDSS, T25FW and Brief-BESTest, therefore,
suggest that people with mild MS can execute several
motor tasks in the clinic without evident impairment
based on visual analysis by a clinician, but subtle
changes in balance are evident and people with mild MS
are aware of the increased challenge to execute these
tasks.
This study evaluated standing postural sway using
inertial motion sensors while subjects stood on a
compliant surface of medium-density foam under the
supposition that the measurement system would be clin-
ically feasible and the foam condition would better dif-
ferentiate subjects with and without MS [23]. While
numerous studies have demonstrated that posturography
can differentiate balance control between subjects with
and without MS [32], balance and mobility assessment
using body-worn sensors and automated data processing
software offer the potential of portability compared to trad-
itional kinematic methodology as well as generalizability to
multiple movement tasks while allowing clinically practical
data collection [22]. In previous studies on minimally
disabled people with MS, body worn gyroscopes identi-
fied significantly more trunk sway than in healthy con-
trol subjects [24] and significant differences in pitch
angle range [36]. Body-worn sensors utilizing technol-
ogy and algorithms similar to devices used in our study
have also demonstrated significantly greater sway accel-
eration amplitude during quiet stance with eyes closed
in subjects with MS compared to control subjects [22].
Unlike these prior studies, evaluation of stance on foam
appears to provide strong levels of discriminative valid-
ity to identify people with minimally impaired MS from
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control subjects without MS. Body-worn sensors may
offer the opportunity for sensitive, objective measures
of assessment, yet provide clinical feasibility due to
portability and automated algorithms for outcome pro-
cessing. More data are needed to compare the benefits
of using body-worn inertial sensors over other instru-
mentation methods.
Conclusions
Postural sway abnormalities in subjects with MS who
are minimally disabled were detected using wireless iner-
tial sensors and may signify a superior sensitivity in the
identification of balance impairment prior to the devel-
opment of clinically evident disability. The relatively
novel use of synchronized body-worn inertial sensors
utilized in our study is the subject of increasing study in
neurological disease [17, 21, 27, 38]. The improved abil-
ity to detect and analyze postural sway abnormalities
through these methods may ultimately improve our un-
derstanding of the association between postural sway
abnormalities and falls in patients with MS [39–41]. De-
velopment of longitudinal studies using synchronized
wireless body-worn sensors, [26] particularly in minim-
ally disabled cohorts, may provide important biomarkers
for the early identification of individuals who may bene-
fit from therapeutic interventions, as well as allow
ongoing assessment of such disease modifying and
symptomatic therapies to prevent falls before the accrual
of significant disability.
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